Veklury Reduces Mortality in Immunocompromised People With COVID-19

Veklury can have significant benefits for immunocompromised people with COVID-19, reducing mortality by 30%.

MARCH 6, 2024

Remdesivir Resistance Found in Immunocompromised Patient

Yale researchers said the discovery raised concerns about the emergence of drug resistance in COVID-19 patients, ...

MARCH 25, 2022

Remdesivir for COVID-19: Where Does It Stand?

Preliminary positive findings led remdesivir to become a staple in the armamentarium to treat hospitalized patients ...

NOVEMBER 9, 2020

FDA Approves Remdesivir, a first for for COVID-19 Treatment

Remdesivir works by inhibiting replication of SARS-CoV-2.

OCTOBER 23, 2020

Remdesivir Use in Patients With Impaired Kidney Function: Weighing Risks Vs Benefits

Although further study is needed, I think it is reasonable to consider not withholding remdesivir therapy based on ...

SEPTEMBER 15, 2020

New Information on Remdesivir for COVID-19 Boosts Initial Optimism; FDA Issues EUA

Enough evidence has trickled in to support the use of the investigational antiviral remdesivir in patients with ...

MAY 3, 2020

Early Data on Remdesivir for COVID-19 Cause Guarded Optimism

Two-thirds of patients with severe COVID-19 treated with remdesivir under a compassionate-use protocol showed ...

APRIL 22, 2020